3184 related articles for article (PubMed ID: 22330011)
1. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
[TBL] [Abstract][Full Text] [Related]
2. Future development of global regulations of Chinese herbal products.
Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.
Uzuner H; Bauer R; Fan TP; Guo DA; Dias A; El-Nezami H; Efferth T; Williamson EM; Heinrich M; Robinson N; Hylands PJ; Hendry BM; Cheng YC; Xu Q
J Ethnopharmacol; 2012 Apr; 140(3):458-68. PubMed ID: 22387462
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
[TBL] [Abstract][Full Text] [Related]
5. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future.
Buriani A; Garcia-Bermejo ML; Bosisio E; Xu Q; Li H; Dong X; Simmonds MS; Carrara M; Tejedor N; Lucio-Cazana J; Hylands PJ
J Ethnopharmacol; 2012 Apr; 140(3):535-44. PubMed ID: 22342380
[TBL] [Abstract][Full Text] [Related]
6. MEDLINE-based assessment of animal studies on Chinese herbal medicine.
Tejedor Garcia N; Garcia Bermejo L; Fernandez Martinez AB; Olmos Centenera G; Kumari R; Xu Q; Cheng X; Watson S; de Lucio Cazaña FJ
J Ethnopharmacol; 2012 Apr; 140(3):545-9. PubMed ID: 22353429
[TBL] [Abstract][Full Text] [Related]
7. [Essential procedure and key methods for survey of traditional knowledge related to Chinese materia medica resources].
Cheng G; Huang LQ; Xue DY; Zhang XB
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4728-31. PubMed ID: 25898568
[TBL] [Abstract][Full Text] [Related]
8. A ten-year audit of traditional Chinese medicine and other natural product research published in the Chinese Medical Journal (2000-2009).
Collins RA
Chin Med J (Engl); 2011 May; 124(9):1401-8. PubMed ID: 21740755
[TBL] [Abstract][Full Text] [Related]
9. Syndrome differentiation in modern research of traditional Chinese medicine.
Jiang M; Lu C; Zhang C; Yang J; Tan Y; Lu A; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):634-42. PubMed ID: 22322251
[TBL] [Abstract][Full Text] [Related]
10. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
[TBL] [Abstract][Full Text] [Related]
11. [Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].
Zhao J; Ye Z
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2193-8. PubMed ID: 23189716
[TBL] [Abstract][Full Text] [Related]
12. [Problems in medicinal materials research of new traditional Chinese medicine].
Zhou G; Wang T; He YP
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3192-5. PubMed ID: 25509314
[TBL] [Abstract][Full Text] [Related]
13. Will the Europe Union's Traditional Herbal Medicinal Products Directive (Directive 2004/24/EC) be against traditional Chinese medicine in EU market?
Xu J; Liu M; Xia Z
J Evid Based Med; 2013 May; 6(2):104-8. PubMed ID: 23829802
[TBL] [Abstract][Full Text] [Related]
14. Knowledge discovery in traditional Chinese medicine: state of the art and perspectives.
Feng Y; Wu Z; Zhou X; Zhou Z; Fan W
Artif Intell Med; 2006 Nov; 38(3):219-36. PubMed ID: 16930966
[TBL] [Abstract][Full Text] [Related]
15. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
Xie PS; Leung AY
J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
[TBL] [Abstract][Full Text] [Related]
16. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicinal materials and their interface with Western medical concepts.
Chan K
J Ethnopharmacol; 2005 Jan; 96(1-2):1-18. PubMed ID: 15588645
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine (phytotherapy): Health Technology Assessment report - selected aspects.
Maxion-Bergemann S; Bornhöft G; Sonderegger E; Renfer A; Matthiessen PF; Wolf U
Forsch Komplementmed; 2006; 13 Suppl 2():30-41. PubMed ID: 16883078
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicine in the treatment of breast cancer.
Cohen I; Tagliaferri M; Tripathy D
Semin Oncol; 2002 Dec; 29(6):563-74. PubMed ID: 12516039
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based Chinese medicine for cancer therapy.
Konkimalla VB; Efferth T
J Ethnopharmacol; 2008 Mar; 116(2):207-10. PubMed ID: 18243610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
